Concurrently Controlled, Dose-Escalation Study to Evaluate the Safety and Efficacy of HMI-102 in Adult PKU Subjects with PAH Deficiency
|Effective start/end date
|10/1/22 → 11/1/22
- HOMOLOGY MEDICINES INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.